These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 1454338)

  • 41. Scleral ulceration after preoperative injection of mitomycin C in the pterygium head.
    Carrasco MA; Rapuano CJ; Cohen EJ; Laibson PR
    Arch Ophthalmol; 2002 Nov; 120(11):1585-6. PubMed ID: 12427079
    [No Abstract]   [Full Text] [Related]  

  • 42. Prospective study on the safety and efficacy of combined conjunctival rotational autograft with intraoperative 0.02% mitomycin C in primary pterygium excision.
    Young AL; Tam PM; Leung GY; Cheng LL; Lam PT; Lam DS
    Cornea; 2009 Feb; 28(2):166-9. PubMed ID: 19158559
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Results of treatment with topical mitomycin C 0.02% following excision of primary pterygium.
    Rachmiel R; Leiba H; Levartovsky S
    Br J Ophthalmol; 1995 Mar; 79(3):233-6. PubMed ID: 7703200
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Amniotic membrane graft for primary pterygium: comparison with conjunctival autograft and topical mitomycin C treatment.
    Ma DH; See LC; Liau SB; Tsai RJ
    Br J Ophthalmol; 2000 Sep; 84(9):973-8. PubMed ID: 10966947
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Limbal conjunctival versus amniotic membrane in the intraoperative application of mitomycin C for recurrent pterygium: a randomized controlled trial.
    Chen R; Huang G; Liu S; Ma W; Yin X; Zhou S
    Graefes Arch Clin Exp Ophthalmol; 2017 Feb; 255(2):375-385. PubMed ID: 27761704
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Long-term effects of mitomycin C in pterygium surgery on scleral thickness and the conjunctival epithelium.
    Solomon A; Kaiserman I; Raiskup FD; Landau D; Frucht-Pery J
    Ophthalmology; 2004 Aug; 111(8):1522-7. PubMed ID: 15288982
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Postoperative instillation of 0.04% mitomycin C in the treatment of primary pterygium in Zaire.
    Kaimbo Wa Kaimbo D
    Bull Soc Belge Ophtalmol; 1996; 261():107-10. PubMed ID: 9009369
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Efficacy and safety of intraoperative mitomycin C as adjunct therapy for pterygium surgery.
    Díaz L; Villegas VM; Emanuelli A; Izquierdo NJ
    Cornea; 2008 Dec; 27(10):1119-21. PubMed ID: 19034124
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Single intraoperative application versus postoperative mitomycin C eye drops in pterygium surgery.
    Cardillo JA; Alves MR; Ambrosio LE; Poterio MB; Jose NK
    Ophthalmology; 1995 Dec; 102(12):1949-52. PubMed ID: 9098301
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Who should receive mitomycin-C after pterygium surgery?
    Sugar A
    Ophthalmology; 1992 Nov; 99(11):1645-6. PubMed ID: 1454337
    [No Abstract]   [Full Text] [Related]  

  • 51. Preoperative injection of mitomycin C in combined pterygium and cataract surgery.
    Avisar R; Bar S; Weinberger D
    Cornea; 2005 May; 24(4):406-9. PubMed ID: 15829795
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of Mitomycin C in Early Conjunctival Inflammation after Pterygium Surgery.
    da Costa Paula C; Julio G; Campos P; Pujol P; Asaad M
    Curr Eye Res; 2017 May; 42(5):696-700. PubMed ID: 27854142
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A randomized trial comparing mitomycin C and conjunctival autograft after excision of primary pterygium.
    Chen PP; Ariyasu RG; Kaza V; LaBree LD; McDonnell PJ
    Am J Ophthalmol; 1995 Aug; 120(2):151-60. PubMed ID: 7639298
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Use of mitomycin C with conjunctival autograft in pterygium surgery in Asian-Canadians.
    Wong VA; Law FC
    Ophthalmology; 1999 Aug; 106(8):1512-5. PubMed ID: 10442896
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Topical mitomycin-C for pterygia: is single application appropriate?
    Rubinfeld RS; Stein RM
    Ophthalmic Surg Lasers; 1997 Aug; 28(8):662-9. PubMed ID: 9268998
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hyperbaric oxygen therapy for mitomycin C-induced scleral necrosis.
    Bayer A; Mutiu FM; Sobaci G
    Ophthalmic Surg Lasers; 2001; 32(6):490-3. PubMed ID: 11725777
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The use of low-dose mitomycin C for prevention of recurrent pterygium.
    Frucht-Pery J; Ilsar M
    Ophthalmology; 1994 Apr; 101(4):759-62. PubMed ID: 8152772
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Combined conjunctival rotational autograft with 0.02% mitomycin C in primary pterygium surgery: a long-term follow-up study.
    Tsim NC; Young AL; Jhanji V; Ho M; Cheng LL
    Br J Ophthalmol; 2015 Oct; 99(10):1396-400. PubMed ID: 25837606
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Intraoperative application of topical mitomycin C for pterygium surgery.
    Frucht-Pery J; Siganos CS; Ilsar M
    Ophthalmology; 1996 Apr; 103(4):674-7. PubMed ID: 8618770
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Recurrence rate of pterygium following surgical excision with intraoperative versus postoperative mitomycin-C.
    Rahman A; Yahya K; Ul Hasan KS
    J Coll Physicians Surg Pak; 2008 Aug; 18(8):489-92. PubMed ID: 18798585
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.